Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease.

Bester J, Buys AV, Lipinski B, Kell DB, Pretorius E.

Front Aging Neurosci. 2013 Dec 6;5:88. doi: 10.3389/fnagi.2013.00088. eCollection 2013.

PMID:
24367334
2.

Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.

Pretorius E, Bester J, Vermeulen N, Lipinski B, Gericke GS, Kell DB.

PLoS One. 2014 Jan 9;9(1):e85271. doi: 10.1371/journal.pone.0085271. eCollection 2014.

PMID:
24416376
3.

The peripheral blood of Aβ binding RBC as a biomarker for diagnosis of Alzheimer's disease.

Lan J, Liu J, Zhao Z, Xue R, Zhang N, Zhang P, Zhao P, Zheng F, Sun X.

Age Ageing. 2015 May;44(3):458-64. doi: 10.1093/ageing/afv009. Epub 2015 Feb 11.

PMID:
25673873
4.

Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease?

Mohanty JG, Eckley DM, Williamson JD, Launer LJ, Rifkind JM.

Adv Exp Med Biol. 2008;614:29-35. doi: 10.1007/978-0-387-74911-2_4.

PMID:
18290311
5.

Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases.

Pretorius E, Kell DB.

Integr Biol (Camb). 2014 May;6(5):486-510. doi: 10.1039/c4ib00025k. Review.

PMID:
24714688
6.

MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.

Bartzokis G, Tishler TA.

Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):821-33.

PMID:
10875443
7.

Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level.

Quintana C, Bellefqih S, Laval JY, Guerquin-Kern JL, Wu TD, Avila J, Ferrer I, Arranz R, Patiño C.

J Struct Biol. 2006 Jan;153(1):42-54. Epub 2005 Dec 1.

PMID:
16364657
8.

Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients.

Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM, Bloxham CA, Perry RH, Edwardson JA, Harrison PM.

Biochem J. 1992 Oct 15;287 ( Pt 2):509-14.

PMID:
1445209
9.

Carbon monoxide and iron modulate plasmatic coagulation in Alzheimer's disease.

Nielsen VG, Pretorius E, Bester J, Jacobsen WK, Boyle PK, Reinhard JP.

Curr Neurovasc Res. 2015;12(1):31-9.

PMID:
25557378
10.

Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.

Piñero DJ, Hu J, Connor JR.

Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):761-76.

PMID:
10875438
11.

Brain capillaries in Alzheimer's disease.

Baloyannis SJ.

Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:152.

PMID:
26665235
12.

Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE.

Ayton S, Faux NG, Bush AI; Alzheimer's Disease Neuroimaging Initiative..

Nat Commun. 2015 May 19;6:6760. doi: 10.1038/ncomms7760.

PMID:
25988319
13.

Cortical iron regulation and inflammatory response in Alzheimer's disease and APPSWE/PS1ΔE9 mice: a histological perspective.

Meadowcroft MD, Connor JR, Yang QX.

Front Neurosci. 2015 Jul 23;9:255. doi: 10.3389/fnins.2015.00255. eCollection 2015.

PMID:
26257600
14.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
15.

Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study.

Buys AV, Van Rooy MJ, Soma P, Van Papendorp D, Lipinski B, Pretorius E.

Cardiovasc Diabetol. 2013 Jan 28;12:25. doi: 10.1186/1475-2840-12-25.

PMID:
23356738
16.

White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.

Lindemer ER, Salat DH, Smith EE, Nguyen K, Fischl B, Greve DN; Alzheimer's Disease Neuroimaging Initiative..

Neurobiol Aging. 2015 Sep;36(9):2447-57. doi: 10.1016/j.neurobiolaging.2015.05.011. Epub 2015 May 28.

PMID:
26095760
17.

The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease.

Raha AA, Vaishnav RA, Friedland RP, Bomford A, Raha-Chowdhury R.

Acta Neuropathol Commun. 2013 Sep 3;1:55. doi: 10.1186/2051-5960-1-55.

PMID:
24252754
18.

Concurrent Alzheimer's pathology in patients with clinical normal pressure hydrocephalus: correlation of high-volume lumbar puncture results, cortical brain biopsies, and outcomes.

Pomeraniec IJ, Bond AE, Lopes MB, Jane JA Sr.

J Neurosurg. 2016 Feb;124(2):382-8. doi: 10.3171/2015.2.JNS142318. Epub 2015 Sep 4.

PMID:
26339853
19.

Amyloid Aβ 42, a promoter of magnetite nanoparticle formation in Alzheimer's disease.

Tahirbegi IB, Pardo WA, Alvira M, Mir M, Samitier J.

Nanotechnology. 2016 Nov 18;27(46):465102. Epub 2016 Oct 13.

PMID:
27734811
20.

Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology.

Mohanty JG, Shukla HD, Williamson JD, Launer LJ, Saxena S, Rifkind JM.

Proteome Sci. 2010 Mar 3;8:11. doi: 10.1186/1477-5956-8-11.

PMID:
20199679

Supplemental Content

Support Center